Joint Formulary & PAD

Cinnarizine - Vestibular disorders

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green
Formulations :
  • Tablets
Associated Icons :
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Cinnarizine
Indication :
Vestibular disorders
Group Name :
Keywords :
nausea and vomiting, vertigo, motion sickness, tinnitus, benign paroxysmal positional vertigo, BPPV, Labyrinthitis, Menieres disease
Brand Names Include :
Stugeron
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Cinnarizine is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Vestibular disorders.

Committee Recommendations (2)

GENERIC Cinnarizine has been considered by the PCN and has been assigned a GREEN traffic light status.

NOTE - the branded product, Stugeron, was considered BLACK at the PCN in MAy 2017.
This drug has been agreed as appropriate for initiation in Primary Care and/or continued in Primary Care following a recommendation from specialists in other health care sectors. Following consideration by the PCN, it has been assigned a GREEN traffic light status